Kathleen Tregoning
CIK 1830764 · See Remarks · last filed 2026-05-29
Kathleen Tregoning is a corporate insider who has filed 17 SEC Form 4 insider transactions across 4 companies since 2020. The most recent filing, for CMPS, was dated May 29, 2026. Across all open-market trades the lifetime net is −$260.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $213.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$213.8K
4
17
-$260.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CMPS | Director | — | $12.08 | — | $0 | 1 | 2026-05-29 |
| SPRO | Director | 75,000 | $2.85 | $213.8K | $0 | 8 | 2025-06-16 |
| Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | See Remarks | 10,666 | $44.96 | $479.5K | -$260.5K | 5 | 2024-01-23 |
| Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | See Remarks | — | $18.07 | — | $0 | 2 | 2021-02-05 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-29 | CMPS | Grant (A) | — | $0 | EDGAR |
| 2025-06-16 | SPRO | Grant (A) | +20,000 | $0 | EDGAR |
| 2024-08-05 | — | Disp (D) | −10,666 | $0 | |
| 2024-05-30 | SPRO | Grant (A) | +20,000 | $0 | EDGAR |
| 2024-01-23 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-04 | SPRO | Grant (A) | — | $0 | EDGAR |
| 2023-12-28 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Exer (M) | +3,150 | $31.7K | EDGAR |
| 2023-12-21 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | +7,516 | -$260.5K | EDGAR |
| 2023-10-10 | SPRO | Grant (A) | +20,000 | $0 | EDGAR |
| 2023-02-08 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | — | $0 | EDGAR |